COMP <GO>
CRCT vs VREX // REVENUE GROWTH (YOY)
Cricut Inc. (Class A) (NASDAQ) VS. Varex Imaging Corporation (NASDAQ) • 15-METRIC TALLY: CRCT 7
— VREX 2
▲ REVENUE GROWTH (YOY) LEADER: VREX
LAST: $6.18 (+1.81%) • MKT CAP: $1.29B
revenue-growth
-0.50%
LAST: $18.44 (-0.05%) • MKT CAP: $776.3M
revenue-growth
4.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRCT VS. VREX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRCT | VREX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.10% | 34.40% | +20.70 | CRCT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | -3.00% | +88.00 | CRCT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.47% | 2.42% | +13.05 | CRCT | /fcf-yield <GO> |
| Operating Margin | 13.50% | -3.30% | +16.80 | CRCT | /operating-margins <GO> |
| Net Profit Margin | 10.80% | -8.30% | +19.10 | CRCT | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -0.50% | 4.10% | -4.60 | VREX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.62 | 1.96 | +3.66 | CRCT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 59.7 | -15.18 | VREX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.29B | $776.3M | $518.0M | CRCT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRCT REV | VREX REV | CRCT GROSS % | VREX GROSS % | CRCT FCF | VREX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $708.8M | $844.6M | 55.1% | 34.4% | $200.2M | $18.8M |
| FY 2024 | $712.5M | $811.0M | 49.5% | 31.7% | $265.0M | $20.4M |
| FY 2023 | $765.1M | $893.4M | — | — | $288.1M | $108.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRCT // BETA —
VREX // BETA —